REVVITY, INC.
RVTYHealthcarerevvity.com
Latest available resultsJuly 5, 2026Quarter · 10-Q filed Aug 11, 2026
Results announcedNovember 3, 2026EPS vs forecast ▲ +4.1%Detailed filing pending
Next reportFebruary 1, 2027after close · forecast 1.657 $/share
Revenue
$729.69M
▲ +1.3% vs prior year YoY
Net income
$51.82M
▼ -3.9% vs prior year YoY
EPS
0.47$
▲ +2.2% vs prior year YoY
Net margin
7.1%
▼ -0.4 pp vs prior year YoY
Revenue▲ +1.3%
Margins (% of revenue)GrossOperatingNet
Net income▼ -3.9%
EPS▲ +2.2%
Financial statements
View 10-Q filed August 11, 2026 on SEC ↗| Metric | Sep 2024 | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Apr 2026 | Jul 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $684.05M | $729.37M | $664.76M | $720.28M | $698.95M | $772.06M | $711.12M | $729.69M | ▲ +1.3% |
| Gross profit | $384.82M | — | $375.55M | $392.56M | $374.60M | — | $387.65M | $416.87M | ▲ +6.2% |
| Operating income | $98.15M | $118.75M | $72.23M | $90.76M | $81.90M | $111.75M | $75.89M | $89.32M | ▼ -1.6% |
| Net income | $94.37M | $94.64M | $42.24M | $53.95M | $46.65M | $98.36M | $40.72M | $51.82M | ▼ -3.9% |
| R&D | $49.14M | $49.21M | $53.60M | $53.27M | $50.80M | $58.18M | $57.89M | $48.97M | ▼ -8.1% |
| EPS (diluted) | 0.77 $ | — | 0.35 $ | 0.46 $ | 0.40 $ | — | 0.36 $ | 0.47 $ | ▲ +2.2% |
| Margins (% of revenue) | |||||||||
| Gross | 56.3 % | — | 56.5 % | 54.5 % | 53.6 % | — | 54.5 % | 57.1 % | ▲ +2.6 pt |
| Operating | 14.3 % | 16.3 % | 10.9 % | 12.6 % | 11.7 % | 14.5 % | 10.7 % | 12.2 % | ▼ -0.4 pt |
| Net | 13.8 % | 13.0 % | 6.4 % | 7.5 % | 6.7 % | 12.7 % | 5.7 % | 7.1 % | ▼ -0.4 pt |
| Balance sheet | |||||||||
| Assets | $12.77B | $12.39B | $12.36B | $12.36B | $12.14B | $12.17B | $12.00B | $12.05B | ▼ -2.6% |
| Liabilities | $4.85B | $4.73B | $4.72B | $4.81B | $4.76B | $4.92B | $4.81B | $4.82B | ▲ +0.2% |
| Equity | $7.92B | $7.67B | $7.64B | $7.56B | $7.38B | $7.25B | $7.18B | $7.23B | ▼ -4.3% |
| Cash | $1.23B | $1.16B | $1.14B | $991.85M | $931.39M | $919.86M | $860.32M | $1.02B | ▲ +3.1% |
| Capital | |||||||||
| Shares outstanding | 121.70M | 120.19M | 117.87M | 116.07M | 113.38M | 111.80M | 111.56M | 111.59M | ▼ -3.9% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.